机构：[1]Radiotherapy Department, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China河北医科大学第四医院[2]Thoracic Surgery Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院[3]Department of Radiation Oncology, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院[4]Radiotherapy Department, The Fourth Hospital of Hebei Medical University, Shijiazhuang, China河北医科大学第四医院
第一作者机构：[1]Radiotherapy Department, The Fourth Hospital of Hebei Medical University - North Gate, Shijiazhuang, China
推荐引用方式(GB/T 7714)：
Wang J.,He M.,Yao J.,et al.A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma[J].ANNALS OF ONCOLOGY.2020,31:S931-S931.doi:10.1016/j.annonc.2020.08.2094.
APA：
Wang, J.,He, M.,Yao, J.,Cheng, Y.&Wu, Y..(2020).A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma.ANNALS OF ONCOLOGY,31,
MLA：
Wang, J.,et al."A prospective study of apatinib in combination with neoadjuvant concurrent chemoradiotherapy for locally advanced esophageal squamous cell carcinoma".ANNALS OF ONCOLOGY 31.(2020):S931-S931
医学